However, a significant direct effect of GLP-1 on pituitary LH release is less likely
The field is rapidly moving beyond single-target GLP-1 agonism: dual and triple agonists, combining GLP-1 with receptors for GIP and/or glucagon, are designed to produce larger weight loss and beneficial metabolic effects
[10] The first amylin analogue to reach the clinic, pramlintide, demonstrated that the pathway could be drugged, but native-style amylin analogues are short-acting and were used as multiple-daily injections, which limited their appeal for weight management
Addiction and Withdrawal Treatment Rybnikov, S
Its good to remember that these medicines dont work for everyone, and some people might get side effects or feel unwell when taking them
Hold the syringe with needle pointing upward and tap gently to move any air bubbles to the top